(Reuters) - U.S. regulators said on Wednesday that Mylan NV's EpiPen products are in shortage due to manufacturing delays that are creating intermittent supply constraints of the emergency allergy treatment.
KINSHASA (Reuters) - Cases of hemorrhagic fever were reported in an area of Congo that is facing an Ebola epidemic as far back as December and the first deaths were reported in January, a spokesman for the World Health Organization said in the capital Kinshasa on Thursday.
(Reuters) - A federal judge blocked the U.S. Drug Enforcement Administration from suspending a Louisiana drug distributor from selling controlled substances over allegations it failed to identify suspicious orders of opioids that were diverted for illicit uses.
(Reuters Health) - More than two-thirds of cannabis dispensaries recommend that pregnant women use marijuana to treat morning sickness even though doctors advise against it because of safety concerns, a U.S. study suggests.
(Reuters) - Three healthcare providers with the U.S. Department of Veterans Affairs were indicted on charges they excessively used biotech MiMedx Group Inc's products on patients after accepting meals, trips and gratuities from the company.
LONDON (Reuters) - British pharma company AstraZeneca said it had sold the rights for Seroquel, a treatment for schizophrenia and bipolar disease, to Luye Pharma Group for $538 million, as part of a strategy to focus on other therapy areas.
(Reuters Health) - Women who eat a lot of fast food may take longer to become pregnant and be more likely to experience infertility than their counterparts who rarely if ever eat these types of meals, a recent study suggests.